Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. May 26, 2021; 9(15): 3567-3575
Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3567
Table 1 Characteristics of the patients
Characteristics
No-block group (n = 15)
Block group (n = 16)
P value
Age (yr)80.1 ± 4.279.6 ± 4.20.740
Body mass index (kg/m2)22.4 ± 2.322.2 ± 2.20.739
Male/female10/510/60.553
ASA II/III11/410/60.398
Duration of surgery (min)60.3 ± 6.959.5 ± 8.30.747
Table 2 The use of intraoperative and postoperative analgesics
Analgesics
No-block group (n = 15)
Block group (n = 16)
P value
Intraoperative remifentanil dose (μg)316.0 ± 62.5103 ± 37.9< 0.01
Fentanyl given by intravenous titration in the PACU (μg)22 ± 8.61.9 ± 4.0< 0.01
Fentanyl consumption by PCIA device in 48 h after operation (μg)406.6 ± 70.9204.3 ± 43.0< 0.01
Table 3 Postoperative visual analog scale during rest and movement
Postoperative time (d)
VAS during rest
VAS during movement
No-block group (n = 15)
Block group (n = 16)
P value
No-block group (n = 15)
Block group (n = 16)
P value
1st3.6 ± 0.52.7 ± 0.4< 0.014.9 ± 0.73.4 ± 0.50.011
2nd3.4 ± 0.63.0 ± 0.6< 0.014.2 ± 0.83.4 ± 0.50.002
Table 4 Complications and adverse events
Complications and adverse events
No-block group (n = 15)
Block group (n = 16)
P value
Dizziness, n (%)6 (40)1 (6.25)0.037
Postoperative nausea and vomiting, n (%)3 (20)1 (6.25)0.333
Respiratory depression, n (%)00/
Severe sedation, n (%)00/